Credence Research Logo

Home » Biotechnology » Liquid Biopsy Market

Global Liquid Biopsy Market By Analytes (Circulating Tumor Cells (CTCs), Circulating Tumor Dna (CtDNA), Extracellular Vesicles (EVs)), By Application (Prognosis, Diagnosis, Therapy Monitoring) – Market Growth, Future Prospects and Competitive Analysis, 2016 – 2030

Price: $4699

Published: | Report ID: 12549 | Report Format : PDF

Key Highlights of the Report

How are the major segments performing in the Liquid Biopsy market?

  • In 2022, the NGS segment accounted for the largest market share. The precision of the tests is being improved, and they are becoming more affordable because of considerable advancements in NGS technology.
  • In 2022, the Workflows segment was anticipated to hold a major share of the global Liquid Biopsy market because it is the primary step in removing possible interferences, preconcentrating the analyte, and, if necessary, changing the analyte into a form that is better suited for detection or separation.
  • In 2022, the RUO segment accounted for the largest share of the market due to an increase in product introductions.
  • In 2022, the Blood segment accounted for the largest market share due to their excellent accuracy and Usage in therapy prescription, and these tests are in greater demand.
  • In 2022, the Circulating Tumor Cells segment was anticipated to hold a major share of the global Liquid Biopsy market owing to the availability of novel CTC-detection products is anticipated to fuel market revenue growth.
  • In 2022, the Instruments segment accounted for the largest market share due to the introduction of new instruments and the improvement of current items credited with the segment’s growth.
  • In 2022, the Lung Cancer segment was anticipated to hold a prominent share of the global Liquid Biopsy market owing to the vast range of uses of liquid biopsy in hospitals for early cancer screening and diagnosis is responsible for the segment’s dominance.
  • In 2022, the Treatment Monitoring segment accounted for the largest market share as it enabled early intervention, enhanced treatment control, and moved decision-making away from reactive actions and toward more proactive early interventions. Liquid biopsies can aid in the improvement of cancer treatments. Early detection’s value is fueling market expansion even more.

What is the Market Size of Liquid Biopsy regarding value?

The global Liquid Biopsy market is anticipated to grow at a substantial CAGR of 18.90% in the upcoming years. The global Liquid Biopsy industry was estimated to be worth USD 4.5 billion in 2022 and was expected to be worth USD 15.11 billion by 2030.

Which Region dominated the Liquid Biopsy market?

In 2022, the North American Region was anticipated to hold the largest global Liquid Biopsy market share. Due to the high incidence of cancer, quick technology improvements, and expanding government initiatives, the liquid biopsy market in North America held the largest revenue share in 2022. Additionally, throughout the projection period, the regional market is anticipated to increase due to new FDA approvals for liquid biopsy testing, quick technological improvements, and fierce competition amongst biotechnology companies.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Which are the key countries in the Liquid Biopsy market?

Due to the growing number of research projects for discovering and developing novel cancer biomarkers and many pharmaceutical companies, the U.S. held a significant market share in the North American area.

In the Asia Pacific area, China and India dominated the industry. Due to growing government initiatives, such as free screening for cervical, breast, and lung cancer, and increased government, research institute, and corporate collaborations for the distribution and supply of these tests, the use of screening tests for cancer has increased past few years.

Liquid Biopsy Market

How is the economy impacting the global Liquid Biopsy growth?

The market for cancer diagnostics as a whole has been considerably impacted by the COVID-19 epidemic. Most countries stopped doing small biopsy operations, appointments, cancer resection surgeries, and consultations. Morbidity and death from COVID-19 rose in cancer patients, and a significant rate of viral transmission was determined.

What is the competitive environment of the Liquid Biopsy market?

Over the projection period, the market expansion is likely to be driven by the liquid biopsy segment’s pipeline of products slated to go on sale in the next years. For instance, Biocept Inc., one of the top companies offering molecular diagnostic services, was granted a South Korean Patent in July 2021 for its recently introduced Primer-Switch technology. Primer-Switch technology uses real-time PCR and related techniques to find uncommon cancer biomarkers by detecting mutations in circulating tumor DNA (ctDNA). The Target Selector pan-TRK assay, a liquid biopsy test to find TRK biomarkers in the blood of cancer patients, was made commercially available by Biocept, Inc. in November 2019.

Executive Summary

What are the key trends in the Liquid Biopsy market?

  • Growing need for non-invasive procedures, increasing applications of liquid biopsy in cancer detection, and several benefits of liquid biopsy over surgical biopsy, including ease of tolerability and speed, are some of the factors anticipated to propel market expansion.
  • Traditional tissue biopsies employ invasive techniques to find tumor cells; liquid biopsies use peripheral blood, which is accessible and more widely used, typically in patients who cannot have surgery.

How are Technological Advancements Affecting the Growth of the Liquid Biopsy Market?

Precision oncology’s fast-developing liquid biopsy technique allows for the least invasive molecular diagnosis and longitudinal monitoring for therapeutic objectives. Quantification and detection of circulating DNA are now routinely used in clinical practice to treat advanced-stage lung cancer. Clinical studies now have additional avenues to explore due to liquid biopsy technologies’ development. It aids in early cancer detection, the identification of therapeutic resistance mechanisms, and the customization of treatment for disease detection, all of which are projected to support market expansion.

Which are the key investments by the Liquid Biopsy market players?

Investors are providing cash to more and more market participants to create new tests. For instance, Delfi Diagnostics, Inc. secured USD 225 million in funding in July 2022 to create a user-friendly and high-performance MCED test. To make the test more affordable for the general public, the business is attempting to do so. Recent years have seen a tremendous advancement in liquid biopsy technologies, which have seen a sharp increase in utilization in clinical settings.

Some major players in the Liquid Biopsy market are Bio-Rad Laboratories, Biocept Inc., Guardant Health, Illumina, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V, and Thermo Fisher Scientific Inc.

What are the Major Driving Factors for the Liquid Biopsy Market?

The market is expanding due to rising demand for quick, less invasive diagnostic tests and cancer prevalence. In addition to being a source of proteomics and genomics data for cancer patients, it helps detect and separate circulating tumor DNA, exosomes, and circulating tumor cells. According to the World Health Organization, cancer is the second common cause of death worldwide. The new liquid biopsy method has several advantages, including quick results, early prognosis, low cost, low risk, overcoming tumor heterogeneity, and non-invasiveness. The acceptance of liquid biopsy among patients worldwide is fueled by all these advantages over conventional diagnosis, which is predicted to greatly increase demand during the projection period.

What are the Major Risks for the Liquid Biopsy Market?

Expensive machinery, research instruments, chemicals, and upkeep are expensive. Growing market growth prospects will result from increased investment in R&D activities, notably in developed and developing economies related to medical equipment and devices. This, therefore, contributes significantly to the market’s difficulty.

Which is the key Workflow in the Liquid Biopsy market?

During the forecast period, the Lung Cancer segment will hold a major share of the global Liquid Biopsy market. WHO estimates that cancer will be the primary cause of 10 million deaths worldwide in 2020. 1.80 million people died in 2020 as a result of the most common of them, lung cancer. With rising prevalence rates, liquid biopsy use is expanding, boosting the whole market. The reproductive application sector is anticipated to increase profitably over the forecast period due to the promising R&D in the liquid biopsy field being considered for treating and maintaining reproductive health. Additionally, segment expansion is facilitated by partnerships and collaborations between market participants in reproductive health.

How is the Liquid Biopsy market performing in regions?

Over the forecast period, Asia Pacific is anticipated to have the fastest CAGR. A growing population, better healthcare infrastructure, and more businesses entering the market are some drivers fueling market expansion. In addition to having a sizable population, Asia Pacific has a high cancer prevalence.

What is the regulatory landscape for the Liquid Biopsy market?

More study on liquid biopsy is being done by several scientists, which helps the market expand. Researchers at Cornell University are working to create a liquid biopsy test that may be used to evaluate and detect COVID-19-related damage to cells, tissues, and organs. The test determines the disease’s severity and forecasts its results. Additionally, it can demonstrate how several organs are involved in disease. This is expected to stimulate R&D spending and accelerate market expansion.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Liquid Biopsy market?

Due to reasons like the rising prevalence of oncology problems, growing demand for minimally invasive cancer diagnostics, and an aging population, the market for liquid biopsy is expanding.

REPORT ATTRIBUTE DETAILS
Liquid Biopsy Market by Value Yes
Liquid Biopsy Market, Tornado Analysis Yes
Liquid Biopsy Market, STAR Analysis Yes
Liquid Biopsy Market, SRC Analysis Yes
Liquid Biopsy Market Pricing Analysis Yes (On Demand)
Liquid Biopsy Market Segment Analysis By Technology (NGS, PCR, FISH, and Others)

By Workflow (Sample Preparation, Library Preparation, Sequencing, and Data Analysis)

By Usage (RUO and Clinical)

By Types of Sample (Blood, Urine, Saliva, and CerebroSpinal Fluid)

By Circulating Biomarkers (Circulating Tumor Cells, Cell-free DNA, Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, and others)

By Product (Test/Services, Kits, Consumabless, and Instruments)

By Indication Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Other cancers, and Non-Oncology Disorders)

By Clinical Application (Treatment Monitoring, Prognosis, and Recurrence Monitoring, Treatment Selection, and Diagnosis and Screening)
Liquid Biopsy Market, Regional Analysis North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and the Rest of the Middle East and Africa)
Liquid Biopsy Market Key Companies Bio-Rad Laboratories, Biocept Inc., Guardant Health, Illumina, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V, and Thermo Fisher Scientific Inc.
Liquid Biopsy Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Segmentation of Global Liquid Biopsy Market-

Global Liquid Biopsy Market – By Technology

  • NGS
  • PCR
  • FISH
  • Other

Global Liquid Biopsy Market – By Workflow

  • Sample Preparation
  • Library Preparation
  • Sequencing
  • Data Analysis

Global Liquid Biopsy Market – By Usage

  • RUO
  • Clinical

Global Liquid Biopsy Market – By Types of Sample

  • Blood
  • Urine
  • Saliva
  • Cerebrospinal Fluid

Global Liquid Biopsy Market – By Circulating Biomarker

  • Circulating Tumor Cells
  • Cell-free DNA
  • Circulating Cell-Free RNA
  • Exosomes and Extracellular Vesicles
  • Others

Global Liquid Biopsy Market – By Products

  • Test/Services
  • Kits and Consumables
  • Instruments

Global Liquid Biopsy Market – By Indication Type

  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Melanoma
  • Other cancers
  • Non-Oncology Disorders

Global Liquid Biopsy Market – By Clinical Application

  • Prognosis and Recurrence Monitoring
  • Treatment Selection
  • Diagnosis and Screening

Global Liquid Biopsy Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Liquid Biopsy Market
2.2. Global Liquid Biopsy Market, By Technology
2.3. Global Liquid Biopsy Market, By Workflow
2.4. Global Liquid Biopsy Market, By Usage
2.5. Global Liquid Biopsy Market, By Types of Sample
2.6. Global Liquid Biopsy Market, By Circulating Biomarker
2.7. Global Liquid Biopsy Market, By Products
2.8. Global Liquid Biopsy Market, By Indication Type
2.9. Global Liquid Biopsy Market, By Clinical Application
2.10. Global Liquid Biopsy Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Liquid Biopsy Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Technology
3.5.2. Workflow
3.5.3. Usage
3.5.4. Types of Sample
3.5.5. Clinical Application
3.5.6. Products
3.5.7. Indication Type
3.5.8. Clinical Application
3.5.9. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Liquid Biopsy Market, By Technology
7.1. Global Liquid Biopsy Market Overview, by Technology
7.1.1. Global Liquid Biopsy Market Revenue Share, By Technology, 2022 Vs 2030 (in %)
7.2. NGS
7.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
7.3. PCR
7.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
7.4. FISH
7.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
7.5. Other
7.5.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

8. Global Liquid Biopsy Market, By Workflow
8.1. Global Liquid Biopsy Market Overview, by Workflow
8.1.1. Global Liquid Biopsy Market, By Workflow, 2022 vs 2030 (in %)
8.2. Sample Preparation
8.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
8.3. Library Preparation
8.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
8.4. Sequencing
8.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
8.5. Data Analysis
8.5.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

9. Global Liquid Biopsy Market, by Usage, 2017-2030 (US$ Bn)
9.1. Global Liquid Biopsy Market Overview, by Usage
9.1.1. Global Liquid Biopsy Market, By Usage, 2022 vs 2030 (in%)
9.2. RUO
9.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
9.3. Clinical
9.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

10. Global Liquid Biopsy Market, by Usage, 2017-2030 (US$ Bn)
10.1. Global Liquid Biopsy Market Overview, by Usage
10.1.1. Global Liquid Biopsy Market, By Usage, 2022 vs 2030 (in%)
10.2. Blood
10.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
10.3. Urine
10.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
10.4. Saliva
10.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
10.5. Cerebro Spinal Fluid
10.5.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

11. Global Liquid Biopsy Market, by Circulating Biomarker, 2017-2030 (US$ Bn)
11.1. Global Liquid Biopsy Market Overview, by Circulating Biomarker
11.1.1. Global Liquid Biopsy Market, By Circulating Biomarker, 2022 vs 2030 (in%)
11.2. Circulating Tumor Cells
11.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
11.3. Cell-free DNA
11.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
11.4. Circulating Cell-Free RNA
11.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
11.5. Exosomes and Extracellular Vesicles
11.5.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
11.6. Others
11.6.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

12. Global Liquid Biopsy Market, by Products, 2017-2030 (US$ Bn)
12.1. Global Liquid Biopsy Market Overview, by Products
12.1.1. Global Liquid Biopsy Market, By Products, 2022 vs 2030 (in%)
12.2. Test/Services
12.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
12.3. Kits and Consumable
12.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
12.4. Instruments
12.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

13. Global Liquid Biopsy Market, by Indication Type, 2017-2030 (US$ Bn)
13.1. Global Liquid Biopsy Market Overview, by Indication Type
13.1.1. Global Liquid Biopsy Market, By Indication Type, 2022 vs 2030 (in%)
13.2. Lung Cancer
13.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
13.3. Breast Cancer
13.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
13.4. Prostate Cancer
13.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
13.5. Colorectal Cancer
13.5.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
13.6. Melanoma
13.6.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
13.7. Other cancers
13.7.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
13.8. Non-Oncology Disorders
13.8.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

14. Global Liquid Biopsy Market, by Clinical Application, 2017-2030 (US$ Bn)
14.1. Global Liquid Biopsy Market Overview, by Clinical Application
14.1.1. Global Liquid Biopsy Market, By Clinical Application, 2022 vs 2030 (in%)
14.2. Treatment Monitoring
14.2.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
14.3. Prognosis and Recurrence Monitoring
14.3.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
14.4. Treatment Selection
14.4.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)
14.5. Diagnosis and Screening
14.5.1. Global Liquid Biopsy Market, By Region, 2017-2030 (US$ Bn)

15. Global Liquid Biopsy Market, By Region
15.1. Global Liquid Biopsy Market Overview, by Region
15.1.1. Global Liquid Biopsy Market, By Region, 2022 vs 2030 (in%)
15.2. Technology
15.2.1. Global Liquid Biopsy Market, By Technology, 2017-2030 (US$ Bn)
15.3. Workflow
15.3.1. Global Liquid Biopsy Market, By Workflow, 2017-2030 (US$ Bn)
15.4. Usage
15.4.1. Global Liquid Biopsy Market, By Usage, 2017-2030 (US$ Bn)
15.5. Types of Sample
15.5.1. Global Liquid Biopsy Market, By Types of Sample, 2017-2030 (US$ Bn)
15.6. Circulating Biomarker
15.6.1. Global Liquid Biopsy Market, By Circulating Biomarker, 2017-2030 (US$ Bn)
15.7. Products
15.7.1. Global Liquid Biopsy Market, By Products, 2017-2030 (US$ Bn)
15.8. Indication Type
15.8.1. Global Liquid Biopsy Market, By Indication Type, 2017-2030 (US$ Bn)
15.9. Clinical Application
15.9.1. Global Liquid Biopsy Market, By Clinical Application, 2017-2030 (US$ Bn)

16. North America Liquid Biopsy Market Analysis
16.1. North America Liquid Biopsy Market, by Technology, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. North America Liquid Biopsy Market, by Workflow, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. North America Liquid Biopsy Market, by Usage, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. North America Liquid Biopsy Market, by Types of Sample, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. North America Liquid Biopsy Market, by Circulating Biomarker, 2017-2030(US$ Bn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. North America Liquid Biopsy Market, by Products, 2017-2030(US$ Bn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. North America Liquid Biopsy Market, by Indication Type, 2017-2030(US$ Bn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. North America Liquid Biopsy Market, by Clinical Application, 2017-2030(US$ Bn)
16.8.1. Overview
16.8.2. SRC Analysis
16.9. North America Liquid Biopsy Market, by Country, 2017-2030 (US$ Bn)
16.9.1. North America Liquid Biopsy Market, by Country, 2022 Vs 2030 (in%)
16.9.2. U.S.
16.9.2.1. U.S. Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.9.2.2. U.S. Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
16.9.2.3. U.S. Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
16.9.2.4. U.S. Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
16.9.2.5. U.S. Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
16.9.2.6. U.S. Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
16.9.2.7. U.S. Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
16.9.2.8. U.S. Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
16.9.2.9. U.S. Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
16.9.3. Canada
16.9.3.1. Canada Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.9.3.2. Canada Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
16.9.3.3. Canada Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
16.9.3.4. Canada Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
16.9.3.5. Canada Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
16.9.3.6. Canada Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
16.9.3.7. Canada Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
16.9.3.8. Canada Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
16.9.3.9. Canada Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
16.9.3.10.
16.9.4. Mexico
16.9.4.1. Mexico Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.9.4.2. Mexico Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
16.9.4.3. Mexico Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
16.9.4.4. Mexico Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
16.9.4.5. Mexico Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
16.9.4.6. Mexico Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
16.9.4.7. Mexico Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
16.9.4.8. Mexico Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
16.9.4.9. Mexico Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)

17. Europe Liquid Biopsy Market Analysis
17.1. Europe Liquid Biopsy Market, by Technology, 2017-2030(US$ Bn)
17.1.1. Overview
17.1.2. SRC Analysis
17.2. Europe Liquid Biopsy Market, by Workflow, 2017-2030(US$ Bn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Europe Liquid Biopsy Market, by Usage, 2017-2030(US$ Bn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Europe Liquid Biopsy Market, by Types of Sample, 2017-2030(US$ Bn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Europe Liquid Biopsy Market, by Circulating Biomarker, 2017-2030(US$ Bn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Europe Liquid Biopsy Market, by Products, 2017-2030(US$ Bn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Europe Liquid Biopsy Market, by Indication Type, 2017-2030(US$ Bn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Europe Liquid Biopsy Market, by Clinical Application, 2017-2030(US$ Bn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. Europe Liquid Biopsy Market, by Country, 2017-2030 (US$ Bn)
17.9.1. Europe Liquid Biopsy Market, by Country, 2022 Vs 2030 (in%)
17.9.2. Germany
17.9.2.1. Germany Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.2.2. Germany Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
17.9.2.3. Germany Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
17.9.2.4. Germany Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
17.9.2.5. Germany Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
17.9.2.6. Germany Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
17.9.2.7. Germany Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
17.9.2.8. Germany Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
17.9.2.9. Germany Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
17.9.3. France
17.9.3.1. France Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.3.2. France Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
17.9.3.3. France Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
17.9.3.4. France Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
17.9.3.5. France Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
17.9.3.6. France Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
17.9.3.7. France Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
17.9.3.8. France Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
17.9.3.9. France Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
17.9.4. UK
17.9.4.1. UK Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.4.2. UK Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
17.9.4.3. UK Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
17.9.4.4. UK Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
17.9.4.5. UK Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
17.9.4.6. UK Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
17.9.4.7. UK Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
17.9.4.8. UK Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
17.9.4.9. UK Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
17.9.5. Italy
17.9.5.1. Italy Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.5.2. Italy Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
17.9.5.3. Italy Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
17.9.5.4. Italy Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
17.9.5.5. Italy Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
17.9.5.6. Italy Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
17.9.5.7. Italy Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
17.9.5.8. Italy Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
17.9.5.9. Italy Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
17.9.6. Spain
17.9.6.1. Spain Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.6.2. Spain Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
17.9.6.3. Spain Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
17.9.6.4. Spain Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
17.9.6.5. Spain Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
17.9.6.6. Spain Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
17.9.6.7. Spain Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
17.9.6.8. Spain Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
17.9.6.9. Spain Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
17.9.7. Rest of Europe
17.9.7.1. Rest of Europe Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.7.2. Rest of Europe Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
17.9.7.3. Rest of Europe Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
17.9.7.4. Rest of Europe Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
17.9.7.5. Rest of Europe Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
17.9.7.6. Rest of Europe Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
17.9.7.7. Rest of Europe Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
17.9.7.8. Rest of Europe Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
17.9.7.9. Rest of Europe Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)

18. Asia Pacific Liquid Biopsy Market Analysis
18.1. Asia Pacific Liquid Biopsy Market, by Technology, 2017-2030(US$ Bn)
18.1.1. Overview
18.1.2. SRC Analysis
18.2. Asia Pacific Liquid Biopsy Market, by Workflow, 2017-2030(US$ Bn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Asia Pacific Liquid Biopsy Market, by Usage, 2017-2030(US$ Bn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Asia Pacific Liquid Biopsy Market, by Types of Sample, 2017-2030(US$ Bn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Asia Pacific Liquid Biopsy Market, by Circulating Biomarker, 2017-2030(US$ Bn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Asia Pacific Liquid Biopsy Market, by Products, 2017-2030(US$ Bn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Asia Pacific Liquid Biopsy Market, by Indication Type, 2017-2030(US$ Bn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Asia Pacific Liquid Biopsy Market, by Clinical Application, 2017-2030(US$ Bn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Asia Pacific Liquid Biopsy Market, by Country, 2017-2030 (US$ Bn)
18.9.1. Asia Pacific Liquid Biopsy Market, by Country, 2022 Vs 2030 (in%)
18.9.2. China
18.9.2.1. China Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.2.2. China Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
18.9.2.3. China Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
18.9.2.4. China Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
18.9.2.5. China Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
18.9.2.6. China Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
18.9.2.7. China Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
18.9.2.8. China Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
18.9.2.9. China Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
18.9.3. Japan
18.9.3.1. Japan Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.3.2. Japan Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
18.9.3.3. Japan Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
18.9.3.4. Japan Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
18.9.3.5. Japan Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
18.9.3.6. Japan Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
18.9.3.7. Japan Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
18.9.3.8. Japan Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
18.9.3.9. Japan Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
18.9.4. India
18.9.4.1. India Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.4.2. India Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
18.9.4.3. India Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
18.9.4.4. India Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
18.9.4.5. India Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
18.9.4.6. India Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
18.9.4.7. India Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
18.9.4.8. India Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
18.9.4.9. India Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
18.9.5. South Korea
18.9.5.1. South Korea Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.5.2. South Korea Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
18.9.5.3. South Korea Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
18.9.5.4. South Korea Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
18.9.5.5. South Korea Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
18.9.5.6. South Korea Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
18.9.5.7. South Korea Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
18.9.5.8. South Korea Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
18.9.5.9. South Korea Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
18.9.6. South-East Asia
18.9.6.1. South-East Asia Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.6.2. South-East Asia Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
18.9.6.3. South-East Asia Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
18.9.6.4. South Korea Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
18.9.6.5. South Korea Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
18.9.6.6. South-East Asia Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
18.9.6.7. South Korea Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
18.9.6.8. South Korea Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
18.9.6.9. South Korea Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
18.9.7. Rest of Asia Pacific
18.9.7.1. Rest of Asia Pacific Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.7.2. Rest of Asia Pacific Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
18.9.7.3. Rest of Asia Pacific Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
18.9.7.4. Rest of Asia Pacific Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
18.9.7.5. Rest of Asia Pacific Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
18.9.7.6. Rest of Asia Pacific Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
18.9.7.7. Rest of Asia Pacific Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
18.9.7.8. Rest of Asia Pacific Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
18.9.7.9. Rest of Asia Pacific Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)

19. Latin America Liquid Biopsy Market Analysis
19.1. Latin America Liquid Biopsy Market, by Technology, 2017-2030(US$ Bn)
19.1.1. Overview
19.1.2. SRC Analysis
19.2. Latin America Liquid Biopsy Market, by Workflow, 2017-2030(US$ Bn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Latin America Liquid Biopsy Market, by Usage, 2017-2030(US$ Bn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Latin America Liquid Biopsy Market, by Types of Sample, 2017-2030(US$ Bn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Latin America Liquid Biopsy Market, by Circulating Biomarker, 2017-2030(US$ Bn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Latin America Liquid Biopsy Market, by Products, 2017-2030(US$ Bn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Latin America Liquid Biopsy Market, by Indication Type, 2017-2030(US$ Bn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Latin America Liquid Biopsy Market, by Clinical Application, 2017-2030(US$ Bn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Latin America Liquid Biopsy Market, by Country, 2017-2030 (US$ Bn)
19.9.1. Latin America Liquid Biopsy Market, by Country, 2022 Vs 2030 (in%)
19.9.2. Brazil
19.9.2.1. Brazil Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
19.9.2.2. Brazil Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
19.9.2.3. Brazil Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
19.9.2.4. Brazil Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
19.9.2.5. Brazil Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
19.9.2.6. Brazil Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
19.9.2.7. Brazil Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
19.9.2.8. Brazil Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
19.9.2.9. Brazil Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
19.9.3. Argentina
19.9.3.1. Argentina Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
19.9.3.2. Argentina Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
19.9.3.3. Argentina Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
19.9.3.4. Argentina Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
19.9.3.5. Argentina Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
19.9.3.6. Argentina Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
19.9.3.7. Argentina Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
19.9.3.8. Argentina Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
19.9.3.9. Argentina Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
19.9.4. Rest of Latin America
19.9.4.1. Rest of Latin America Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
19.9.4.2. Rest of Latin America Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
19.9.4.3. Rest of Latin America Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
19.9.4.4. Rest of Latin America Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
19.9.4.5. Rest of Latin America Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
19.9.4.6. Rest of Latin America Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
19.9.4.7. Rest of Latin America Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
19.9.4.8. Rest of Latin America Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
19.9.4.9. Rest of Latin America Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)

20. Middle East and Africa Liquid Biopsy Market Analysis
20.1. Middle East and Africa Liquid Biopsy Market, by Technology, 2017-2030(US$ Bn)
20.1.1. Overview
20.1.2. SRC Analysis
20.2. Middle East and Africa Liquid Biopsy Market, by Workflow, 2017-2030(US$ Bn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Middle East and Africa Liquid Biopsy Market, by Usage, 2017-2030(US$ Bn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Middle East and Africa Liquid Biopsy Market, by Types of Sample, 2017-2030(US$ Bn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Middle East and Africa Liquid Biopsy Market, by Circulating Biomarker, 2017-2030(US$ Bn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Middle East and Africa Liquid Biopsy Market, by Products, 2017-2030(US$ Bn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Middle East and Africa Liquid Biopsy Market, by Indication Type, 2017-2030(US$ Bn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Middle East and Africa Liquid Biopsy Market, by Clinical Application, 2017-2030(US$ Bn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Middle East and Africa Liquid Biopsy Market, by Country, 2017-2030 (US$ Bn)
20.9.1. Middle East and Africa Liquid Biopsy Market, by Country, 2022 Vs 2030 (in%)
20.9.2. GCC Countries
20.9.2.1. GCC Countries Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
20.9.2.2. GCC Countries Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
20.9.2.3. GCC Countries Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
20.9.2.4. GCC Countries Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
20.9.2.5. GCC Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
20.9.2.6. GCC Countries Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
20.9.2.7. GCC Countries Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
20.9.2.8. GCC Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
20.9.2.9. GCC Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
20.9.3. South Africa
20.9.3.1. South Africa Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
20.9.3.2. South Africa Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
20.9.3.3. South Africa Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
20.9.3.4. South Africa Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
20.9.3.5. South Africa Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
20.9.3.6. South Africa Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
20.9.3.7. South Africa Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
20.9.3.8. South Africa Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
20.9.3.9. South Africa Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)
20.9.4. Rest of Middle East and Africa
20.9.4.1. Rest of Middle East and Africa Liquid Biopsy Market Estimates and Forecast, 2017-2030 (US$ Bn)
20.9.4.2. Rest of Middle East and Africa Liquid Biopsy, By Technology, 2017-2030 (US$ Bn)
20.9.4.3. Rest of Middle East and Africa Liquid Biopsy, By Workflow, 2017-2030 (US$ Bn)
20.9.4.4. Rest of Middle East and Africa Liquid Biopsy, By Usage, 2017-2030 (US$ Bn)
20.9.4.5. Rest of Middle East and Africa Liquid Biopsy, By Types of Sample, 2017-2030 (US$ Bn)
20.9.4.6. Rest of Middle East and Africa Liquid Biopsy, By Circulating Biomarker, 2017-2030 (US$ Bn)
20.9.4.7. Rest of Middle East and Africa Liquid Biopsy, By Products, 2017-2030 (US$ Bn)
20.9.4.8. Rest of Middle East and Africa Liquid Biopsy, By Indication Type, 2017-2030 (US$ Bn)
20.9.4.9. Rest of Middle East and Africa Liquid Biopsy, By Clinical Application, 2017-2030 (US$ Bn)

21. Company Profiles
21.1. Bio-Rad Laboratories
21.1.1. Company Overview
21.1.2. Products/Services Portfolio
21.1.3. Geographical Presence
21.1.4. Financial Summary
21.1.4.1. Market Revenue and Net Profit (2019-2022)
21.1.4.2. Business Segment Revenue Analysis
21.1.4.3. Geographical Revenue Analysis
21.2. Biocept Inc.
21.3. Guardant Health
21.4. Illumina, Inc.
21.5. F. Hoffmann-La Roche Ltd.
21.6. Johnson & Johnson
21.7. Laboratory Corporation of America Holdings
21.8. MDxHealth SA
21.9. QIAGEN N.V
21.10. Thermo Fisher Scientific Inc.

 

List of Figures
FIG. 1 Global Liquid Biopsy Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Liquid Biopsy Market Segment
FIG. 4 Global Liquid Biopsy Market, by Technology, 2022 (US$ Bn)
FIG. 5 Global Liquid Biopsy Market, by Workflow, 2022 (US$ Bn)
FIG. 6 Global Liquid Biopsy Market, by Usage, 2022 (US$ Bn)
FIG. 7 Global Liquid Biopsy Market, by Types of Sample, 2022 (US$ Bn)
FIG. 8 Global Liquid Biopsy Market, by Circulating Biomarker, 2022 (US$ Bn)
FIG. 9 Global Liquid Biopsy Market, by Products, 2022 (US$ Bn)
FIG. 10 Global Liquid Biopsy Market, by Indication Type, 2022 (US$ Bn)
FIG. 11 Global Liquid Biopsy Market, by Clinical Application, 2022 (US$ Bn)
FIG. 12 Global Liquid Biopsy Market, by Geography, 2022 (US$ Bn)
FIG. 13 Attractive Investment Proposition, by Technology, 2022
FIG. 14 Attractive Investment Proposition, by Workflow, 2022
FIG. 15 Attractive Investment Proposition, by Usage, 2022
FIG. 16 Attractive Investment Proposition, by Types of Sample, 2022
FIG. 17 Attractive Investment Proposition, by Circulating Biomarker, 2022
FIG. 18 Attractive Investment Proposition, by Products, 2022
FIG. 19 Attractive Investment Proposition, by Indication Type, 2022
FIG. 20 Attractive Investment Proposition, by Clinical Application, 2022
FIG. 21 Attractive Investment Proposition, by Geography, 2022
FIG. 22 Global Market Share Analysis of Key Liquid Biopsy Market Manufacturers, 2022
FIG. 23 Global Market Positioning of Key Liquid Biopsy Market Manufacturers, 2022
FIG. 24 Global Liquid Biopsy Market Value Contribution, By Technology, 2022 & 2030 (Value %)
FIG. 25 Global Liquid Biopsy Market, by NGS, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Liquid Biopsy Market, by PCR, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Liquid Biopsy Market, by FISH, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Liquid Biopsy Market Value Contribution, By Workflow, 2022 & 2030 (Value %)
FIG. 29 Global Liquid Biopsy Market, by Sample Preparation, Value, 2017-2030 (US$ Bn)
FIG. 30 Global Liquid Biopsy Market, by Library Preparation, 2017-2030 (US$ Bn)
FIG. 31 Global Liquid Biopsy Market, by Library Sequencing, 2017-2030 (US$ Bn)
FIG. 32 Global Liquid Biopsy Market, by Data Analysis, 2017-2030 (US$ Bn)
FIG. 33 Global Liquid Biopsy Market Value Contribution, By Usage, 2022 & 2030 (Value %)
FIG. 34 Global Liquid Biopsy Market, by RUO, Value, 2017-2030 (US$ Bn)
FIG. 35 Global Liquid Biopsy Market, by Clinical, 2017-2030 (US$ Bn)
FIG. 36 Global Liquid Biopsy Market Value Contribution, By Types of Sample, 2022 & 2030 (Value %)
FIG. 37 Global Liquid Biopsy Market, by Blood, Value, 2017-2030 (US$ Bn)
FIG. 38 Global Liquid Biopsy Market, by Urine, 2017-2030 (US$ Bn)
FIG. 39 Global Liquid Biopsy Market, by Saliva, 2017-2030 (US$ Bn)
FIG. 40 Global Liquid Biopsy Market, by CerebroSpinal Fluid, Value, 2017-2030 (US$ Bn)
FIG. 41 Global Liquid Biopsy Market Value Contribution, By Circulating Biomarker, 2022 & 2030 (Value %)
FIG. 42 Global Liquid Biopsy Market, by Circulating Tumor Cells, 2017-2030 (US$ Bn)
FIG. 43 Global Liquid Biopsy Market, by Cell-free DNA, 2017-2030 (US$ Bn)
FIG. 44 Global Liquid Biopsy Market, by Circulating Cell-Free RNA, 2017-2030 (US$ Bn)
FIG. 45 Global Liquid Biopsy Market, by EXOSOMES AND EXTRACELLULAR VESICLES, 2017-2030 (US$ Bn)
FIG. 46 Global Liquid Biopsy Market, by Others, 2017-2030 (US$ Bn)
FIG. 47 Global Liquid Biopsy Market Value Contribution, By Products, 2022 & 2030 (Value %)
FIG. 48 Global Liquid Biopsy Market, by Test/Services, 2017-2030 (US$ Bn)
FIG. 49 Global Liquid Biopsy Market, by Kits and Consumable, 2017-2030 (US$ Bn)
FIG. 50 Global Liquid Biopsy Market, by Instruments, 2017-2030 (US$ Bn)
FIG. 51 Global Liquid Biopsy Market Value Contribution, By Indication Type, 2022 & 2030 (Value %)
FIG. 52 Global Liquid Biopsy Market, by Lung Cancer, 2017-2030 (US$ Bn)
FIG. 53 Global Liquid Biopsy Market, by Breast Cancer, 2017-2030 (US$ Bn)
FIG. 54 Global Liquid Biopsy Market, by Prostate Cancer, 2017-2030 (US$ Bn)
FIG. 55 Global Liquid Biopsy Market, by Colorectal Cancer, 2017-2030 (US$ Bn)
FIG. 56 Global Liquid Biopsy Market, by Melanoma, 2017-2030 (US$ Bn)
FIG. 57 Global Liquid Biopsy Market, by Other cancers, 2017-2030 (US$ Bn)
FIG. 58 Global Liquid Biopsy Market, by Non-Oncology Disorders, 2017-2030 (US$ Bn)
FIG. 59 Global Liquid Biopsy Market Value Contribution, By Clinical Application, 2022 & 2030 (Value %)
FIG. 60 Global Liquid Biopsy Market, by Treatment Monitoring, 2017-2030 (US$ Bn)
FIG. 61 Global Liquid Biopsy Market, by Prognosis and Recurrence Monitoring, 2017-2030 (US$ Bn)
FIG. 62 Global Liquid Biopsy Market, by Treatment Selection, 2017-2030 (US$ Bn)
FIG. 63 Global Liquid Biopsy Market, by Diagnosis and Screening, 2017-2030 (US$ Bn)
FIG. 64 North America Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 65 North America Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 66 U.S. Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 67 Canada Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 68 Europe Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 69 Germany Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 70 France Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 71 U.K. Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 72 Italy Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 73 Spain Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 74 Rest of Europe Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 75 Asia Pacific Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 76 China Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 77 Japan Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 78 India Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 79 South Korea Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 80 South-East Asia Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 81 Rest of Asia Pacific Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 82 Latin America Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 83 Brazil Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 84 Mexico Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 85 Rest of Latin America Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 86 Middle East & Africa Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 87 GCC Countries Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 88 South Africa Liquid Biopsy Market, 2017-2030 (US$ Bn)
FIG. 89 Rest of Middle East and Africa Liquid Biopsy Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Liquid Biopsy Market
TABLE 2 Global Liquid Biopsy Market: Market Drivers Impact Analysis
TABLE 3 Global Liquid Biopsy Market: Market Restraints Impact Analysis
TABLE 4 Global Liquid Biopsy Market, by Competitive Benchmarking, 2022
TABLE 5 Global Liquid Biopsy Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Liquid Biopsy Market, by Key Strategies Analysis, 2022
TABLE 7 Global Liquid Biopsy Market, by NGS, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Liquid Biopsy Market, by NGS, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Liquid Biopsy Market, by PCR, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Liquid Biopsy Market, by PCR, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Liquid Biopsy Market, by FISH, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Liquid Biopsy Market, by FISH, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Liquid Biopsy Market, by Sample Preparation, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Liquid Biopsy Market, by Sample Preparation, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Liquid Biopsy Market, by Library Preparation, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Liquid Biopsy Market, by Library Preparation, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Liquid Biopsy Market, by Sequencing, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Liquid Biopsy Market, by Sequencing, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Liquid Biopsy Market, by Data Analysis, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Liquid Biopsy Market, by Data Analysis, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Liquid Biopsy Market, by RUO, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Liquid Biopsy Market, by RUO, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Liquid Biopsy Market, by Clinical, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Liquid Biopsy Market, by Clinical, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Liquid Biopsy Market, by Blood, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Liquid Biopsy Market, by Blood, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Liquid Biopsy Market, by RUO, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Liquid Biopsy Market, by RUO, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Liquid Biopsy Market, by Clinical, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Liquid Biopsy Market, by Clinical, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Liquid Biopsy Market, by Blood, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Liquid Biopsy Market, by Blood, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Liquid Biopsy Market, by RUO, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Liquid Biopsy Market, by RUO, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Liquid Biopsy Market, by Clinical, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global Liquid Biopsy Market, by Clinical, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global Liquid Biopsy Market, by Blood, By Region, 2017-2022 (US$ Bn)
TABLE 38 Global Liquid Biopsy Market, by Blood, By Region, 2023-2030 (US$ Bn)
TABLE 39 Global Liquid Biopsy Market, by RUO, By Region, 2017-2022 (US$ Bn)
TABLE 40 Global Liquid Biopsy Market, by RUO, By Region, 2023-2030 (US$ Bn)
TABLE 41 Global Liquid Biopsy Market, by Clinical, By Region, 2017-2022 (US$ Bn)
TABLE 42 Global Liquid Biopsy Market, by Clinical, By Region, 2023-2030 (US$ Bn)
TABLE 43 Global Liquid Biopsy Market, by Blood, By Region, 2017-2022 (US$ Bn)
TABLE 44 Global Liquid Biopsy Market, by Blood, By Region, 2023-2030 (US$ Bn)
TABLE 45 Global Liquid Biopsy Market, by RUO, By Region, 2017-2022 (US$ Bn)
TABLE 46 Global Liquid Biopsy Market, by RUO, By Region, 2023-2030 (US$ Bn)
TABLE 47 Global Liquid Biopsy Market, by Clinical, By Region, 2017-2022 (US$ Bn)
TABLE 48 Global Liquid Biopsy Market, by Clinical, By Region, 2023-2030 (US$ Bn)
TABLE 49 Global Liquid Biopsy Market, by Blood, By Region, 2017-2022 (US$ Bn)
TABLE 50 Global Liquid Biopsy Market, by Blood, By Region, 2023-2030 (US$ Bn)
TABLE 51 Global Liquid Biopsy Market, by Urine, By Region, 2017-2022 (US$ Bn)
TABLE 52 Global Liquid Biopsy Market, by Urine, By Region, 2023-2030 (US$ Bn)
TABLE 53 Global Liquid Biopsy Market, by Saliva, By Region, 2017-2022 (US$ Bn)
TABLE 54 Global Liquid Biopsy Market, by Saliva, By Region, 2023-2030 (US$ Bn)
TABLE 55 Global Liquid Biopsy Market, by CerebroSpinal Fluid, By Region, 2017-2022 (US$ Bn)
TABLE 56 Global Liquid Biopsy Market, by CerebroSpinal Fluid, By Region, 2023-2030 (US$ Bn)
TABLE 57 Global Liquid Biopsy Market, by Circulating Tumor Cells, By Region, 2017-2022 (US$ Bn)
TABLE 58 Global Liquid Biopsy Market, by Circulating Tumor Cells, By Region, 2023-2030 (US$ Bn)
TABLE 59 Global Liquid Biopsy Market, by Cell-free DNA, By Region, 2017-2022 (US$ Bn)
TABLE 60 Global Liquid Biopsy Market, by Cell-free DNA, By Region, 2023-2030 (US$ Bn)
TABLE 61 Global Liquid Biopsy Market, by Circulating Cell-Free RNA, By Region, 2017-2022 (US$ Bn)
TABLE 62 Global Liquid Biopsy Market, by Circulating Cell-Free RNA, By Region, 2023-2030 (US$ Bn)
TABLE 63 Global Liquid Biopsy Market, by Exosomes and Extracellular Vesicles, By Region, 2017-2022 (US$ Bn)
TABLE 64 Global Liquid Biopsy Market, by Exosomes and Extracellular Vesicles, By Region, 2023-2030 (US$ Bn)
TABLE 65 Global Liquid Biopsy Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 66 Global Liquid Biopsy Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 67 Global Liquid Biopsy Market, by Test/Services, By Region, 2017-2022 (US$ Bn)
TABLE 68 Global Liquid Biopsy Market, by Test/Services, By Region, 2023-2030 (US$ Bn)
TABLE 69 Global Liquid Biopsy Market, by Kits and Consumable, By Region, 2017-2022 (US$ Bn)
TABLE 70 Global Liquid Biopsy Market, by Kits and Consumable, By Region, 2023-2030 (US$ Bn)
TABLE 71 Global Liquid Biopsy Market, by Instruments, By Region, 2017-2022 (US$ Bn)
TABLE 72 Global Liquid Biopsy Market, by Instruments, By Region, 2023-2030 (US$ Bn)
TABLE 73 Global Liquid Biopsy Market, by Lung Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 74 Global Liquid Biopsy Market, by Lung Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 75 Global Liquid Biopsy Market, by Breast Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 76 Global Liquid Biopsy Market, by Breast Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 77 Global Liquid Biopsy Market, by Prostate Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 78 Global Liquid Biopsy Market, by Prostate Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 79 Global Liquid Biopsy Market, by Colorectal Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 80 Global Liquid Biopsy Market, by Colorectal Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 81 Global Liquid Biopsy Market, by Melanoma, By Region, 2017-2022 (US$ Bn)
TABLE 82 Global Liquid Biopsy Market, by Melanoma, By Region, 2023-2030 (US$ Bn)
TABLE 83 Global Liquid Biopsy Market, by Other cancers, By Region, 2017-2022 (US$ Bn)
TABLE 84 Global Liquid Biopsy Market, by Other cancers, By Region, 2023-2030 (US$ Bn)
TABLE 85 Global Liquid Biopsy Market, by Non-Oncology Disorders, By Region, 2017-2022 (US$ Bn)
TABLE 86 Global Liquid Biopsy Market, by Non-Oncology Disorders, By Region, 2023-2030 (US$ Bn)
TABLE 87 Global Liquid Biopsy Market, by Treatment Monitoring, By Region, 2017-2022 (US$ Bn)
TABLE 88 Global Liquid Biopsy Market, by Treatment Monitoring, By Region, 2023-2030 (US$ Bn)
TABLE 89 Global Liquid Biopsy Market, by Prognosis and Recurrence Monitoring, By Region, 2017-2022 (US$ Bn)
TABLE 90 Global Liquid Biopsy Market, by Prognosis and Recurrence Monitoring, By Region, 2023-2030 (US$ Bn)
TABLE 91 Global Liquid Biopsy Market, by Treatment Selection, By Region, 2017-2022 (US$ Bn)
TABLE 92 Global Liquid Biopsy Market, by Treatment Selection, By Region, 2023-2030 (US$ Bn)
TABLE 93 Global Liquid Biopsy Market, by Diagnosis and Screening, By Region, 2017-2022 (US$ Bn)
TABLE 94 Global Liquid Biopsy Market, by Diagnosis and Screening, By Region, 2023-2030 (US$ Bn)
TABLE 95 Global Liquid Biopsy Market, by Region, 2017-2022 (US$ Bn)
TABLE 96 Global Liquid Biopsy Market, by Region, 2023-2030 (US$ Bn)
TABLE 97 North America Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 98 North America Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 99 North America Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 100 North America Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 101 North America Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 102 North America Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 103 North America Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 104 North America Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 105 North America Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 106 North America Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 107 North America Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 108 North America Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 109 North America Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 110 North America Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 111 North America Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 112 North America Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 113 North America Liquid Biopsy Market, by Country, 2017-2022 (US$ Bn)
TABLE 114 North America Liquid Biopsy Market, by Country, 2023-2030 (US$ Bn)
TABLE 115 United States Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 116 United States Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 117 United States Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 118 United States Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 119 United States Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 120 United States Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 121 United States Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 122 United States Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 123 United States Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 124 United States Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 125 United States Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 126 United States Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 127 United States Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 128 United States Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 129 United States Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 130 United States Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 131 Canada Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 132 Canada Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 133 Canada Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 134 Canada Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 135 Canada Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 136 Canada Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 137 Canada Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 138 Canada Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 139 Canada Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 140 Canada Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 141 Canada Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 142 Canada Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 143 Canada Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 144 Canada Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 145 Canada Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 146 Canada Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 147 Europe Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 148 Europe Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 149 Europe Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 150 Europe Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 151 Europe Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 152 Europe Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 153 Europe Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 154 Europe Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 155 Europe Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 156 Europe Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 157 Europe Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 158 Europe Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 159 Europe Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 160 Europe Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 161 Europe Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 162 Europe Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 163 Europe Liquid Biopsy Market, by Country, 2017-2022 (US$ Bn)
TABLE 164 Europe Liquid Biopsy Market, by Country, 2023-2030 (US$ Bn)
TABLE 165 Germany Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 166 Germany Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 167 Germany Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 168 Germany Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 169 Germany Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 170 Germany Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 171 Germany Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 172 Germany Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 173 Germany Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 174 Germany Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 175 Germany Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 176 Germany Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 177 Germany Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 178 Germany Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 179 Germany Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 180 Germany Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 181 France Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 182 France Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 183 France Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 184 France Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 185 France Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 186 France Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 187 France Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 188 France Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 189 France Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 190 France Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 191 France Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 192 France Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 193 France Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 194 France Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 195 France Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 196 France Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 197 United Kingdom Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 198 United Kingdom Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 199 United Kingdom Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 200 United Kingdom Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 201 United Kingdom Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 202 United Kingdom Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 203 United Kingdom Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 204 United Kingdom Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 205 United Kingdom Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 206 United Kingdom Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 207 United Kingdom Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 208 United Kingdom Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 209 United Kingdom Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 210 United Kingdom Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 211 United Kingdom Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 212 United Kingdom Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 213 Italy Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 214 Italy Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 215 Italy Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 216 Italy Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 217 Italy Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 218 Italy Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 219 Italy Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 220 Italy Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 221 Italy Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 222 Italy Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 223 Italy Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 224 Italy Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 225 Italy Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 226 Italy Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 227 Italy Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 228 Italy Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 229 Spain Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 230 Spain Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 231 Spain Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 232 Spain Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 233 Spain Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 234 Spain Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 235 Spain Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 236 Spain Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 237 Spain Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 238 Spain Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 239 Spain Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 240 Spain Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 241 Spain Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 242 Spain Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 243 Spain Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 244 Spain Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 245 Rest of Europe Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 246 Rest of Europe Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 247 Rest of Europe Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 248 Rest of Europe Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 249 Rest of Europe Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 250 Rest of Europe Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 251 Rest of Europe Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 252 Rest of Europe Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 253 Rest of Europe Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 254 Rest of Europe Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 255 Rest of Europe Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 256 Rest of Europe Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 257 Rest of Europe Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 258 Rest of Europe Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 259 Rest of Europe Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 260 Rest of Europe Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 261 Asia Pacific Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 262 Asia Pacific Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 263 Asia Pacific Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 264 Asia Pacific Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 265 Asia Pacific Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 266 Asia Pacific Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 267 Asia Pacific Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 268 Asia Pacific Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 269 Asia Pacific Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 270 Asia Pacific Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 271 Asia Pacific Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 272 Asia Pacific Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 273 Asia Pacific Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 274 Asia Pacific Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 275 Asia Pacific Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 276 Asia Pacific Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 277 China Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 278 China Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 279 China Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 280 China Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 281 China Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 282 China Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 283 China Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 284 China Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 285 China Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 286 China Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 287 China Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 288 China Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 289 China Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 290 China Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 291 China Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 292 China Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 293 Japan Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 294 Japan Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 295 Japan Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 296 Japan Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 297 Japan Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 298 Japan Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 299 Japan Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 300 Japan Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 301 Japan Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 302 Japan Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 303 Japan Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 304 Japan Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 305 Japan Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 306 Japan Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 307 Japan Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 308 Japan Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 309 India Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 310 India Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 311 India Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 312 India Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 313 India Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 314 India Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 315 India Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 316 India Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 317 India Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 318 India Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 319 India Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 320 India Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 321 India Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 322 India Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 323 India Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 324 India Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 325 South Korea Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 326 South Korea Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 327 South Korea Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 328 South Korea Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 329 South Korea Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 330 South Korea Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 331 South Korea Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 332 South Korea Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 333 South Korea Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 334 South Korea Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 335 South Korea Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 336 South Korea Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 337 South Korea Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 338 South Korea Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 339 South Korea Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 340 South Korea Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 341 South-East Asia Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 342 South-East Asia Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 343 South-East Asia Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 344 South-East Asia Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 345 South-East Asia Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 346 South-East Asia Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 347 South-East Asia Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 348 South-East Asia Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 349 South-East Asia Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 350 South-East Asia Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 351 South-East Asia Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 352 South-East Asia Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 353 South-East Asia Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 354 South-East Asia Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 355 South-East Asia Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 356 South-East Asia Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 357 Rest of Asia Pacific Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 358 Rest of Asia Pacific Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 359 Rest of Asia Pacific Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 360 Rest of Asia Pacific Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 361 Rest of Asia Pacific Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 362 Rest of Asia Pacific Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 363 Rest of Asia Pacific Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 364 Rest of Asia Pacific Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 365 Rest of Asia Pacific Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 366 Rest of Asia Pacific Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 367 Rest of Asia Pacific Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 368 Rest of Asia Pacific Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 369 Rest of Asia Pacific Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 370 Rest of Asia Pacific Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 371 Rest of Asia Pacific Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 372 Rest of Asia Pacific Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 373 Latin America Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 374 Latin America Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 375 Latin America Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 376 Latin America Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 377 Latin America Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 378 Latin America Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 379 Latin America Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 380 Latin America Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 381 Latin America Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 382 Latin America Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 383 Latin America Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 384 Latin America Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 385 Latin America Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 386 Latin America Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 387 Latin America Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 388 Latin America Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 389 Brazil Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 390 Brazil Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 391 Brazil Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 392 Brazil Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 393 Brazil Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 394 Brazil Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 395 Brazil Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 396 Brazil Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 397 Brazil Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 398 Brazil Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 399 Brazil Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 400 Brazil Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 401 Brazil Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 402 Brazil Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 403 Brazil Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 404 Brazil Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 405 Argentina Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 406 Argentina Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 407 Argentina Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 408 Argentina Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 409 Argentina Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 410 Argentina Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 411 Argentina Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 412 Argentina Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 413 Argentina Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 414 Argentina Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 415 Argentina Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 416 Argentina Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 417 Argentina Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 418 Argentina Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 419 Argentina Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 420 Argentina Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 421 Rest of Latin America Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 422 Rest of Latin America Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 423 Rest of Latin America Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 424 Rest of Latin America Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 425 Rest of Latin America Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 426 Rest of Latin America Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 427 Rest of Latin America Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 428 Rest of Latin America Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 429 Rest of Latin America Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 430 Rest of Latin America Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 431 Rest of Latin America Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 432 Rest of Latin America Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 433 Rest of Latin America Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 434 Rest of Latin America Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 435 Rest of Latin America Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 436 Rest of Latin America Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 437 Middle East and Africa Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 438 Middle East and Africa Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 439 Middle East and Africa Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 440 Middle East and Africa Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 441 Middle East and Africa Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 442 Middle East and Africa Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 443 Middle East and Africa Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 444 Middle East and Africa Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 445 Middle East and Africa Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 446 Middle East and Africa Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 447 Middle East and Africa Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 448 Middle East and Africa Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 449 Middle East and Africa Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 450 Middle East and Africa Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 451 Middle East and Africa Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 452 Middle East and Africa Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 453 GCC Countries Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 454 GCC Countries Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 455 GCC Countries Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 456 GCC Countries Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 457 GCC Countries Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 458 GCC Countries Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 459 GCC Countries Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 460 GCC Countries Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 461 GCC Countries Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 462 GCC Countries Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 463 GCC Countries Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 464 GCC Countries Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 465 GCC Countries Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 466 GCC Countries Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 467 GCC Countries Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 468 GCC Countries Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 469 South Africa Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 470 South Africa Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 471 South Africa Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 472 South Africa Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 473 South Africa Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 474 South Africa Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 475 South Africa Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 476 South Africa Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 477 South Africa Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 478 South Africa Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 479 South Africa Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 480 South Africa Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 481 South Africa Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 482 South Africa Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 483 South Africa Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 484 South Africa Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)
TABLE 485 Rest of Middle East and Africa Liquid Biopsy Market, by Technology, 2017-2022 (US$ Bn)
TABLE 486 Rest of Middle East and Africa Liquid Biopsy Market, by Technology, 2023-2030 (US$ Bn)
TABLE 487 Rest of Middle East and Africa Liquid Biopsy Market, by Workflow, 2017-2022 (US$ Bn)
TABLE 488 Rest of Middle East and Africa Liquid Biopsy Market, by Workflow, 2023-2030 (US$ Bn)
TABLE 489 Rest of Middle East and Africa Liquid Biopsy Market, by Usage, 2017-2022 (US$ Bn)
TABLE 490 Rest of Middle East and Africa Liquid Biopsy Market, by Usage, 2023-2030 (US$ Bn)
TABLE 491 Rest of Middle East and Africa Liquid Biopsy Market, by Types of Sample, 2017-2022 (US$ Bn)
TABLE 492 Rest of Middle East and Africa Liquid Biopsy Market, by Types of Sample, 2023-2030 (US$ Bn)
TABLE 493 Rest of Middle East and Africa Liquid Biopsy Market, by Circulating Biomarker, 2017-2022 (US$ Bn)
TABLE 494 Rest of Middle East and Africa Liquid Biopsy Market, by Circulating Biomarker, 2023-2030 (US$ Bn)
TABLE 495 Rest of Middle East and Africa Liquid Biopsy Market, by Products, 2017-2022 (US$ Bn)
TABLE 496 Rest of Middle East and Africa Liquid Biopsy Market, by Products, 2023-2030 (US$ Bn)
TABLE 497 Rest of Middle East and Africa Liquid Biopsy Market, by Indication Type, 2017-2022 (US$ Bn)
TABLE 498 Rest of Middle East and Africa Liquid Biopsy Market, by Indication Type, 2023-2030 (US$ Bn)
TABLE 499 Rest of Middle East and Africa Liquid Biopsy Market, by Clinical Application, 2017-2022 (US$ Bn)
TABLE 500 Rest of Middle East and Africa Liquid Biopsy Market, by Clinical Application, 2023-2030 (US$ Bn)

Frequently asked questions :

How does COVID-19 Impact the global Liquid Biopsy market?

COVID-19 has considerably impacted the market due to the growing number of cases, lockdown implications imposed by the government, and a reduced number of elective surgeries.

Which is the leading Region of the market for Liquid Biopsy?

North America accounted for the largest market share of the global Liquid Biopsy market.

What are the key drivers for the growth of the Liquid Biopsy market?

Increasing demand for cancer testing, growing investments, and rising R&D activities to drive the Liquid Biopsy market.

Which is the major segment in the Liquid Biopsy market by technology?

The NGS segment had a major share of the global market in 2022.

Which is the major segment in the Liquid Biopsy market by Usage?

The ROU segment had a major share in the global market.

Related Reports By Keyword

Nylon Films for Liquid Packaging Market

Published:
Report ID: 62946

Liquid Crystal Tunable Filter Market

Published:
Report ID: 12558

Liquid Crystal Polymers Market

Published:
Report ID: 59848

Liquid Waste Management Market

Published:
Report ID: 12633

Liquid Fertilizer Market

Published:
Report ID: 58778

Liquid Smoke Market

Published:
Report ID: 12614

Liquid Chromatography Instruments Market

Published:
Report ID: 54111

Liquid Packaging Carton Market

Published:
Report ID: 52623

Rapid Liquid Printing Market

Published:
Report ID: 52223

Related Reports

U.S. Occupational Health Market

Published:
Report ID: 62072

UK Occupational Health Market

Published:
Report ID: 62267

South Korea Occupational Health market

Published:
Report ID: 62069

Japan Occupational Health Market

Published:
Report ID: 62062

Germany Occupational Health Market

Published:
Report ID: 61983

China Occupational Health Market

Published:
Report ID: 61963

Australia Occupational Health Market

Published:
Report ID: 61938

Brazil Occupational Health Market

Published:
Report ID: 61947

Canada Occupational Health Market

Published:
Report ID: 61957

Cell Expansion Market

Published:
Report ID: 3198

Sterilization Indicators Market

Published:
Report ID: 9803

Nutrigenomics Market

Published:
Report ID: 14289

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$7699

Request Free Sample

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
Request Free Sample